Shared Clinical Decision Making(SCDM)
RSV Vaccination for Adults 60 years and Older
• Respiratory syncytial virus (RSV) is a cause of severe respiratory illness across the lifespan. Each year in the
United States, RSV leads to approximately 60,000-160,000 hospitalizations and 6,000-10,000 deaths among
adults 65 years and older.
• Adults 60 years of age and older now have the option to receive one dose of RSV vaccine based on a SCDM
process between a patient and their health care provider.
• Consider multiple factors when discussing RSV vaccination with your patients. SCDM recommendations are
optional and are informed by whether the patient has any risk factors for severe RSV disease; a patient’s
risk of exposure to RSV; a patient’s preferences for RSV vaccination; and the clinical discretion of the health
care provider.